Intriguingly, the combination of GLP-1 RAs with anticancer drugs may indirectly inhibit tumor migration, invasion, and growth by increasing the chemosensitivity of cancer cells [32,35]
Monitoring recommendations Researchers using cagrilintide should consider regular monitoring including: Blood work every 3 to 6 months including metabolic panel, lipid panel, liver function, and pancreatic enzymes Thyroid function tests at baseline and periodically Body composition assessment to track lean mass versus fat mass changes Heart rate monitoring particularly during titration Nutritional status markers including vitamin B12, iron, and vitamin D The peptide research and studies section provides broader context for evaluating emerging safety data as it becomes available
Instead of taking glutathione beauty supplements
BYETTA (exenatide) injection
Chen H, Li J, Li N, Liu H, Tang J
Oral glutathione users from the Handog study report 90% satisfaction with moderate skin lightening